CClinicalTrials.gg
Status unknownNCT04139707Updated Mar 24, 2020

A Mobile Application for Training of Family Caregivers Caring for Someone With Dementia

An interventional study of Caring4Dementia and White Paper in Dementia, sponsored by University of Manitoba. Status unknown at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-03-24.

Sponsored by University of Manitoba · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Background

The mental, physical, and emotional health of caregivers is negatively affected by the burden of caring for of persons living with dementia. Caregivers are usually reported as feeling frustrated, angry, exhausted, guilty, helpless and unable to bear the heavy burden of their caregiving responsibilities. In addition to depressive symptoms and other mental health problems among caregivers, the physical stress of caring for someone who is unable to perform daily activities such as bathing, grooming and other personal care, has been shown to be a serious threat to caregivers' physical health outcomes. Evidence has shown that greater levels of stress, anxiety, depression, frustration, and lower subjective well-being and self-efficacy are exhibited in a greater amount among family and friends who care for persons living with dementia compared to those who do not have the burden of caring for a persons living with dementia. Caregivers have been shown to use alcohol and other drugs at a higher rate than those who do not need to care for others as a reaction to this increased stress. Studies has also shown that caregivers are more likely than non-Caregivers to use opioid or psychotropic medications. One over five caregivers (22%) feel tired when they go to bed at night.

Objectives

This study relies on a mobile application (Caring4Dementia) that provides people, caring for a person living with dementia, with a useful and intuitive training tool targeting communication skills. The aims of this study are to evaluate the feasibility and acceptability of using Caring4Dementia within a self-administered program and the preliminary efficacy of the Caring4Dementia intervention.

02

Conditions studied

  • Dementia

Browse trials for

Keywords

  • dementia
  • care-giving
  • communication
  • mobile application
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's planned enrollment of 120 is above the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

University of Manitoba is the lead sponsor of 542 studies on the registry; 87 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 5 (42%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Informal caregiver of a person living with dementia for more than 6 months
  • Able to read and understand English
  • Able to use smartphones and tablets (Apple or Android)
  • Have a smartphone or tablet (Apple or Android) with internet connection, involved in this study
  • 18 years or over
  • Give written and oral informed consent

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Caring4Dementia Group

    The experimental group will receive Careing4Dementia downloadable on their smartphone or tablet. Caring4Dementia will tell and show caregivers of a person living with dementia how to 1) manage difficult behaviors, 2) deal with refusal, 3) deal with tensions and 4) manage work-life demands. The app is self-administered and self-paced and contains surveys referring to the outcome measurements tools used in the study. The intervention will be for 30 days without any restriction or limitation in terms of timing, location or frequency of use.

    Device: Caring4Dementia

  • Active comparator
    White Paper Group

    The White Paper group will receive a white paper on the principles of communicating efficiently with persons living with dementia.

    Other: White Paper

  • No intervention
    Control Goup

    The control group will not receive any intervention.

Interventions

  • DeviceCaring4Dementia

    A mobile application administered for 30 days, which provides people caring for a person living with dementia with a useful and intuitive tool targeting communication skills.

  • OtherWhite Paper

    The White Paper group will receive a white paper (hard copy and electronically) on the principles of communicating efficiently with persons living with dementia.

06

What researchers measure

Primary outcomes

  1. Change in caregiver well-being

    Measured by the Caregiver Well-Being Scale to determine the frequency in which basic needs and activities of living have been met for the caregiver within the last three months. Items in this self-reported scale are scored on a 5-point scale \[ranging form "Rarely (1)" to "Usually (5)"\], with a higher dimension score indicating greater intensity in that dimension. The highest score possible is 70, meaning a higher well-being.

    Time frame: Baseline (Day 1), post (day 30), Retention (90 days) after baseline

Secondary outcomes

  1. Change in caregiver burden

    Measured by the Short version of the Burden Scale for Family Caregivers. This is a 10-item instrument. Each item is a statement that is rated on a 4-point scale with the values "strongly disagree" (0), "disagree" (1), "agree" (2), and "strongly agree" (3). The scale ranges from 0 to 30, with a higher dimension score indicating greater intensity in that dimension.

    Time frame: Baseline (Day 1), post (day 30), Retention (90 days) after baseline

  2. Change in caregivers' perceived challenges and resources

    Measured by the Adult Carer Quality of Life Questionnaire, a 40-item instrument that measures the overall quality of life for adult carers, and subscale scores for eight domains of quality of life. Scores on the overall questionnaire have a possible range of 0 to 120 with higher scores indicating greater quality of life.

    Time frame: Baseline (Day 1), post (day 30), Retention (90 days) after baseline

  3. Activity volume on the Caring4Dementia app

    Usage logs will be saved on the cloud to quantify the time (s) spent on every activity for all the activities.

    Time frame: 30 days

  4. Activity frequency on the Caring4Dementia app

    Usage logs will be saved on the cloud to quantify the frequency of use of every activity in the application for all the activities (how many time per day the caregiver engage in the activity).

    Time frame: 30 days

07

Study locations

1 of 1 sites recruiting
  • Riverview Health Centre
    Winnipeg, Manitoba, Canada
    • M Klassen · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04139707
Lead sponsor
University of Manitoba
Responsible party
Amine Choukou (Assistant Professor, University of Manitoba) — Principal investigator
First posted
Oct 25, 2019
Start date
Jan 2, 2020
Primary completion
Jul 31, 2020 (estimated)
Completion
Jul 31, 2020 (estimated)
Last update
Mar 24, 2020

Study contacts

Amine Choukou, PhD
Contact
amine.choukou@umanitoba.ca
+12047893412

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion